ALMOTRIPTAN MALATE PDF

In addition, it is expected that almotriptan malate (AXERT®) is generally Trial to Evaluate the Efficacy of Almotriptan Malate (AXERT®) Milligram. Almotriptan is a headache medicine that narrows blood vessels around the brain. Almotriptan also reduces substances in the body that can. Almotriptan is a triptan drug for the treatment of migraine headaches. Almotriptan Malate, Tablet, coated, mg/1, Oral, Patriot Pharmaceuticals,

Author: Meztimuro Mojora
Country: Hungary
Language: English (Spanish)
Genre: Health and Food
Published (Last): 8 November 2009
Pages: 346
PDF File Size: 20.78 Mb
ePub File Size: 11.62 Mb
ISBN: 665-3-50489-688-3
Downloads: 8044
Price: Free* [*Free Regsitration Required]
Uploader: Midal

Eltoprazine The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Eltoprazine. Biperiden The metabolism of Almotriptan can be decreased when combined with Biperiden. Drug information contained herein may be time sensitive.

Clorazepate The risk or severity of adverse effects can be al,otriptan when Clorazepate is combined with Almotriptan.

Gepirone The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Gepirone.

Carprofen Carprofen may decrease the excretion rate of Almotriptan which could result in a higher serum level. Cyclizine Malte risk or severity of adverse effects can be increased when Almotriptan is combined with Cyclizine. Try again or let us know at contact Migraine.

Axert (almotriptan malate) dose, indications, adverse effects, interactions from

Fabomotizole The risk or severity of adverse effects can be increased when Almotriptan is combined with Fabomotizole. Ciprofloxacin The metabolism of Almotriptan can be decreased when combined with Ciprofloxacin.

Major The plasma concentrations of almotriptan may be elevated when administered concurrently with ciprofloxacin. Cinazepam The risk or severity of adverse effects can be increased when Almotriptan is combined with Cinazepam.

Dienogest Almotriptan may decrease the excretion rate of Dienogest which could result in a higher serum level. Beclamide The risk or severity of adverse effects can be increased when Almotriptan is combined with Beclamide. Difenoxin The risk or severity of adverse effects can be increased when Almotriptan is combined with Difenoxin. Gepefrine The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Gepefrine.

  LENIN IN ZURICH BY ALEXANDER SOLZHENITSYN PDF

Dutasteride The metabolism of Dutasteride can be decreased when combined with Almotriptan. Major Ombitasvir; paritaprevir; ritonavir may increase the systemic exposure of almotriptan. Ambroxol The metabolism of Ambroxol can be decreased when combined with Almotriptan. Gabapentin The risk or severity of adverse effects can be increased when Almotriptan is combined with Gabapentin.

Acepromazine The risk or severity of adverse effects can be increased when Almotriptan is combined with Acepromazine. Bendazac Bendazac may decrease the excretion rate of Almotriptan which could result in a higher serum level. a,motriptan

Axert® (almotriptan malate)

The maximum dosage in a hour period is 2 tablets. Amoxapine The metabolism of Amoxapine can be decreased when combined with Almotriptan. Amikacin Amikacin may decrease the excretion rate of Almotriptan which could result in a higher serum level.

Cefamandole Cefamandole may decrease the excretion rate of Almotriptan which almofriptan result in a higher serum level. Major Because of the potential risk and severity of serotonin syndrome, caution should be observed when administering a selective serotonin norepinephrine reuptake inhibitor SNRI like desvenlafaxine with other drugs that have serotonergic properties such as serotonin-receptor agonists e.

Ammonium chloride Almotriptan may decrease the excretion rate of Ammonium chloride which could result in a higher serum level. It is not known whether hemodialysis removes almotriptan from plasma.

Drotebanol The risk or severity of adverse effects can be increased when Almotriptan is combined with Drotebanol. Anastrozole The metabolism of Almotriptan can be decreased when combined with Anastrozole. Risk factors can include a recent dose increase of the sertonergic antidepressant or the addition of other serotonergic medications to an existing antidepressant regimen.

This page was last edited on 28 Octoberat Mqlate Etonogestrel may decrease the excretion rate of Almotriptan which could result in a higher serum level.

Chromous sulfate Almotriptan may decrease the nalate rate of Chromous sulfate which could result in a higher serum level. Patients receiving this combination should be monitored almotrptan the emergence of serotonin syndrome or Neuroleptic Malignant Syndrome NMS like signs and symptoms.

  EYAL WEIZMAN PDF

If concomitant treatment of tramadol and a serotonin-receptor agonist is clinically warranted, careful observation of the patient is advised, especially during the initial time both drugs are used together and during a dose increase of either tramadol or the serotonin-receptor agonist. Dacarbazine Dacarbazine may decrease the excretion rate of Almotriptan which could result in a higher serum level. Decamethonium The risk or severity of adverse effects can be increased when Almotriptan is combined with Decamethonium.

Chloroquine The metabolism of Almotriptan can be decreased when combined with Chloroquine. Acetylsalicylic acid Acetylsalicylic acid may decrease the excretion rate of Almotriptan which could result in a higher serum level. Rare reports of transient and permanent blindness and significant partial vision loss have been reported with the use of 5-HT1-agonists. Cevimeline Cevimeline may decrease the excretion rate of Almotriptan which could result in a higher serum level.

However, as a single mg intravenous dose, fosaprepitant only weakly inhibits CYP3A4 for a duration of 2 days; there is no evidence of CYP3A4 induction. Etynodiol The metabolism of Etynodiol can be decreased when combined with Almotriptan. Artenimol The almtoriptan of Almotriptan can be decreased when combined with Artenimol. Major There is an increased risk of serotonin syndrome during concurrent use of drugs with central serotonergic properties such as lithium and serotonin-receptor agonists.

Cefalotin Cefalotin may decrease the excretion rate of Almotriptan which could result in a higher serum level. Deanol The risk or severity of adverse effects can be increased when Almotriptan is combined with Deanol.

Posted in Art